Contemporary treatment approaches to primary immune deficiencies
Refined immunoglobulin replacement therapy improves humoral immunodeficiency real-world outcomes; learn to distinguish between these genetic conditions and the contemporary multidisciplinary approach to treatment
Learning objectives
You will learn:
- Approaches to identifying patients who may have a primary immunodeficiency disorder and differential diagnoses for hypogammaglobulinaemia
- Goals of treatment and a guideline-recommended approach to initial therapy
- The key outcomes of clinical trials and real-world evidence demonstrating improved outcomes with the use of immune globulin subcutaneous (human) 20% solution as immunoglobulin replacement therapy.
To access this module, please register or login: